Controversy over whether AstraZeneca-Oxford University’s Corona 19 vaccine is effective for the elderly has also been controversial, and observations that the European Medicines Agency (EMA) may grant approval for use only for young people.
According to the British Guardian and BBC Broadcasting, the Commissioner of the European Medicines Agency (EMA) attended the European Parliament’s Health Committee on the 26th (local time) to answer questions from lawmakers, excluding the possibility of approving AstraZeneca vaccines only for certain age groups. I didn’t.
“We don’t want to be confused because there is a scientific and professional discussion going on,” he said. “There is a possibility that a conclusion will be made to approve use by focusing on a specific age group, and a conclusion may be drawn to target a wider age group.”
Commissioner Cook pointed out that studies have been conducted on only a very small number of people to date regarding whether the AstraZeneca vaccine is effective for the elderly. “What the research data means about the population for which the research has been conducted, as well as the population that has not been studied, We are trying to find out what is expected (when vaccinated).”
EMA is currently reviewing approval for conditional marketing of the AstraZeneca vaccine.
The results of the judging will be released on the 29th.
The controversy that the AstraZeneca vaccine is not effective for the elderly was recently presented by the German media.
German economic journal Handelsblatt quoted a government official on the 25th and reported that the AstraZeneca vaccine is only 8% effective in the elderly over the age of 65.
Daily Bild also released a similar report on the same day.
Later, the two newspapers also reported forecasts from government officials that the EMA would not approve the use of the AstraZeneca vaccine for seniors over 65.
AstraZeneca and the German government immediately denied that the report was true.
AstraZeneca vaccine is currently approved for emergency and limited use in the UK, Brazil, Argentina, Mexico, and India.
– .
